CAMP4 Therapeutics (CAMP) vs Evommune (EVMN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
CAMP4 Therapeutics is the larger company by market cap ($241.0 million vs $225.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CAMP | EVMN |
|---|---|---|
| Share price | $3.84 | $6.22 |
| Market cap | $240.97M | $225.74M |
| 1-day change | -3.03% | -5.90% |
| YTD return | -37.36% | -63.67% |
| 1-year return | +16.72% | — |
| EPS (TTM) | $-2.32 | $-3.75 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.75 | $33.20 |
| 52-week low | $2.86 | $6.08 |
| Distance from 52-week high | -50.45% | -81.27% |
| Average volume | 279.95K | 675.52K |
| Shares outstanding | 62.75M | 36.29M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
CAMP vs EVMN FAQ
Which is bigger, CAMP4 Therapeutics or Evommune?
CAMP4 Therapeutics (CAMP) is larger, with a market capitalization of $240.97M compared with $225.74M for Evommune (EVMN).
Are CAMP4 Therapeutics and Evommune in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.